Professional Documents
Culture Documents
CAS-No. 64-17-5
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified uses Reagent for analysis, Chemical production
In compliance with the conditions described in the annex to
this safety data sheet.
Hazard pictograms
Page 1 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Signal word
Danger
Hazard statements
H225 Highly flammable liquid and vapour.
H319 Causes serious eye irritation.
Precautionary statements
Prevention
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources.
No smoking.
P240 Ground/bond container and receiving equipment.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue rinsing.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
Signal word
Danger
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Index-No. 603-002-00-5
64-17-5 01-2119457610-
Page 2 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
For the full text of the H-Statements mentioned in this Section, see Section 16.
3.2 Mixture
Not applicable
4.2 Most important symptoms and effects, both acute and delayed
irritant effects, respiratory paralysis, Dizziness, narcosis, inebriation, euphoria,
Nausea, Vomiting
4.3 Indication of any immediate medical attention and special treatment needed
No information available.
Page 3 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Page 4 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Worker DNEL, longterm Systemic effects dermal 343 mg/kg Body weight
Engineering measures
Technical measures and appropriate working operations should be given priority
over the use of personal protective equipment.
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Colour colourless
Odour alcohol-like
pH 7,0
at 10 g/l
20 °C
Flash point 13 °C
Method: c.c.
Page 6 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Water solubility at 20 °C
completely miscible
Page 7 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Repeated or prolonged exposure may cause skin irritation and dermatitis, due to
degreasing properties of the product.
Page 8 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Eye irritation
Rabbit
Result: Eye irritation
OECD Test Guideline 405
Causes serious eye irritation.
Sensitisation
Local lymph node assay (LLNA) Mouse
Result: negative
Method: OECD Test Guideline 429
Teratogenicity
This information is not available.
Specific target organ toxicity - single exposure
This information is not available.
Specific target organ toxicity - repeated exposure
This information is not available.
Aspiration hazard
This information is not available.
Page 9 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Toxicity to fish
flow-through test EC50 Pimephales promelas (fathead minnow): 15.300 mg/l; 96 h
Analytical monitoring: yes
US-EPA
Toxicity to daphnia and other aquatic invertebrates
EC50 Daphnia magna (Water flea): 9.268 - 14.221 mg/l; 48 h
(IUCLID)
Toxicity to algae
IC5 Scenedesmus quadricauda (Green algae): 5.000 mg/l; 7 d
(Lit.)
Toxicity to bacteria
EC5 Pseudomonas putida: 6.500 mg/l; 16 h
(IUCLID)
Toxicity to daphnia and other aquatic invertebrates (Chronic toxicity)
semi-static test NOEC Daphnia magna (Water flea): 9,6 mg/l; 9 d
(ECHA)
12.2 Persistence and degradability
Biodegradability
94 %
OECD Test Guideline 301E
Readily biodegradable
Biochemical Oxygen Demand (BOD)
930 - 1.670 mg/g (5 d)
(Lit.)
Theoretical oxygen demand (ThOD)
2.100 mg/g
(Lit.)
Ratio COD/ThBOD
90 %
(Lit.)
12.3 Bioaccumulative potential
Partition coefficient: n-octanol/water
log Pow: -0,31
(experimental)
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Page 11 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
14.7 Transport in bulk according to Annex II of MARPOL 73/78 and the IBC
Code
Not relevant
Substances of very high concern (SVHC) This product does not contain
substances of very high concern
according to Regulation (EC) No
1907/2006 (REACH), Article 57
above the respective regulatory
concentration limit of ≥ 0.1 %
(w/w).
National legislation
Storage class 3
Training advice
Provide adequate information, instruction and training for operators.
Page 12 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Labelling
Hazard pictograms
Signal word
Danger
Hazard statements
H225 Highly flammable liquid and vapour.
H319 Causes serious eye irritation.
Precautionary statements
Prevention
P210 Keep away from heat/sparks/open flames/hot surfaces. No smoking.
P240 Ground/bond container and receiving equipment.
Response
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue rinsing.
Storage
P403 + P233 Store in a well-ventilated place. Keep container tightly closed.
Key or legend to abbreviations and acronyms used in the safety data sheet
Used abbreviations and acronyms can be looked up at www.wikipedia.org.
Regional representation
This information is given on the authorised Safety Data Sheet for your country.
The information contained herein is based on the present state of our knowledge. It characterises the
product with regard to the appropriate safety precautions. It does not represent a guarantee of any
properties of the product.
Page 13 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Sectors of end-use
SU 3 Industrial uses: Uses of substances as such or in preparations at industrial
sites
SU9 Manufacture of fine chemicals
SU 10 Formulation [mixing] of preparations and/ or re-packaging (excluding alloys)
Chemical product category
PC19 Intermediate
PC21 Laboratory chemicals
Process categories
PROC1 Use in closed process, no likelihood of exposure
PROC2 Use in closed, continuous process with occasional controlled exposure
PROC3 Use in closed batch process (synthesis or formulation)
PROC4 Use in batch and other process (synthesis) where opportunity for exposure
arises
PROC5 Mixing or blending in batch processes for formulation of preparations and
articles (multistage and/ or significant contact)
PROC8a Transfer of substance or preparation (charging/ discharging) from/ to vessels/
large containers at non-dedicated facilities
PROC8b Transfer of substance or preparation (charging/ discharging) from/ to vessels/
large containers at dedicated facilities
PROC9 Transfer of substance or preparation into small containers (dedicated filling line,
including weighing)
PROC10 Roller application or brushing
PROC14 Production of preparations or articles by tabletting, compression, extrusion,
pelletisation
PROC15 Use as laboratory reagent
Environmental Release Categories
ERC1 Manufacture of substances
ERC2 Formulation of preparations
ERC4 Industrial use of processing aids in processes and products, not becoming part
of articles
ERC6a Industrial use resulting in manufacture of another substance (use of
intermediates)
Amount used
Annual amount per site 400000 t
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Amount used
Annual amount per site 75000 t
2.3 Contributing scenario controlling worker exposure for: PROC1, PROC2, PROC3,
PROC4, PROC5, PROC8a, PROC8b, PROC9, PROC10, PROC14, PROC15
Product characteristics
Concentration of the Covers the percentage of the substance in the product
Substance in Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) High volatile liquid
Additional good practice advice beyond the REACH Chemical Safety Assessment
Additional good practice Wear suitable gloves (tested to EN374) and eye
advice protection.
Page 15 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Page 16 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Workers
Exposure duration, route, Exposure Assessment
CS Use descriptor effect RCR Method
2.3 PROC1 longterm, inhalative, systemic < 0,01 ECETOC TRA 3
longterm, dermal, systemic < 0,01 ECETOC TRA 3
longterm, combined, systemic < 0,01
2.3 PROC2 longterm, inhalative, systemic 0,05 ECETOC TRA 3
longterm, dermal, systemic < 0,01 ECETOC TRA 3
longterm, combined, systemic 0,05
2.3 PROC3 longterm, inhalative, systemic 0,10 ECETOC TRA 3
longterm, dermal, systemic < 0,01 ECETOC TRA 3
longterm, combined, systemic 0,10
2.3 PROC4 longterm, inhalative, systemic 0,20 ECETOC TRA 3
longterm, dermal, systemic 0,02 ECETOC TRA 3
longterm, combined, systemic 0,22
2.3 PROC5 longterm, inhalative, systemic 0,50 ECETOC TRA 3
longterm, dermal, systemic 0,04 ECETOC TRA 3
longterm, combined, systemic 0,54
2.3 PROC8a longterm, inhalative, systemic 0,50 ECETOC TRA 3
longterm, dermal, systemic 0,04 ECETOC TRA 3
longterm, combined, systemic 0,54
2.3 PROC8b longterm, inhalative, systemic 0,30 ECETOC TRA 3
longterm, dermal, systemic 0,04 ECETOC TRA 3
longterm, combined, systemic 0,34
2.3 PROC9 longterm, inhalative, systemic 0,40 ECETOC TRA 3
longterm, dermal, systemic 0,02 ECETOC TRA 3
longterm, combined, systemic 0,42
2.3 PROC10 longterm, inhalative, systemic 0,50 ECETOC TRA 3
longterm, dermal, systemic 0,08 ECETOC TRA 3
longterm, combined, systemic 0,58
2.3 PROC14 longterm, inhalative, systemic 0,50 ECETOC TRA 3
longterm, dermal, systemic 0,01 ECETOC TRA 3
longterm, combined, systemic 0,51
2.3 PROC15 longterm, inhalative, systemic 0,10 ECETOC TRA 3
longterm, dermal, systemic < 0,01 ECETOC TRA 3
longterm, combined, systemic 0,10
The default parameters and -efficiencies of the applied exposure assessment model were
used for the calculation (unless stated differently).
Page 17 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
4. Guidance to Downstream User to evaluate whether he works inside the boundaries set
by the Exposure Scenario
For scaling of worker exposure assessments performed with ECETOC TRA, please consult
the Merck tool ScIDeEx® at www.merckmillipore.com/scideex.
Page 18 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Sectors of end-use
SU 22 Professional uses: Public domain (administration, education, entertainment,
services, craftsmen)
Chemical product category
PC21 Laboratory chemicals
Process categories
PROC15 Use as laboratory reagent
Environmental Release Categories
ERC2 Formulation of preparations
ERC6a Industrial use resulting in manufacture of another substance (use of
intermediates)
Amount used
Annual amount per site 75000 t
Amount used
Annual amount per site 400000 t
Page 19 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
Product characteristics
Concentration of the Covers the percentage of the substance in the product
Substance in Mixture/Article up to 100 % (unless stated differently).
Physical Form (at time of use) High volatile liquid
Additional good practice advice beyond the REACH Chemical Safety Assessment
Additional good practice Wear suitable gloves (tested to EN374) and eye
advice protection.
Workers
Exposure duration, route, Exposure Assessment
CS Use descriptor effect RCR Method
2.3 PROC15 longterm, inhalative, systemic 0,10 ECETOC TRA 3
longterm, dermal, systemic < 0,01 ECETOC TRA 3
longterm, combined, systemic 0,10
The default parameters and -efficiencies of the applied exposure assessment model were
used for the calculation (unless stated differently).
Page 20 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada
SAFETY DATA SHEET
according to Regulation (EC) No. 1907/2006
4. Guidance to Downstream User to evaluate whether he works inside the boundaries set
by the Exposure Scenario
For scaling of worker exposure assessments performed with ECETOC TRA, please consult
the Merck tool ScIDeEx® at www.merckmillipore.com/scideex.
The branding on the header and/or footer of this document may temporarily not visually
match the product purchased as we transition our branding. However, all of the
information in the document regarding the product remains unchanged and matches the
product ordered. For further information please contact mlsbranding@sial.com.
Page 21 of 21
The life science business of Merck operates as MilliporeSigma in the US and Canada